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ABSTRACT
Objective: To evaluate whether methylene blue (MB) could minimize the effects of 
ischemia-reperfusion injury in the nonischemic lung on a lung transplantation rodent 
model. Methods: Forty female Sprague-Dawley rats were divided into 20 donors and 
20 recipients. The 20 recipient rats were divided into two groups (n = 10) according 
to the treatment (0.9% saline vs. 1% MB solutions). All animals underwent unilateral 
lung transplantation. Recipients received 2 mL of saline or MB intraperitoneally prior to 
transplantation. After 2 h of reperfusion, the animals were euthanized and histopathological 
and immunohistochemical analyses were performed in the nonischemic lung. Results: 
There was a signifi cant decrease in infl ammation—neutrophil count and intercellular 
adhesion molecule-1 (ICAM-1) expression in lung parenchyma were higher in the saline 
group in comparison with the MB group—and in apoptosis—caspase-3 expression was 
higher in the saline group and Bcl-2 expression was higher in MB group. Conclusions: 
MB is an effective drug for the protection of nonischemic lungs against infl ammation and 
apoptosis following unilateral lung transplantation in rats.
Keywords: Reperfusion injury; Methylene blue; Lung transplantation; Apoptosis; 
Infl ammation.
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INTRODUCTION
The etiology of ischemia-reperfusion injury (IRI) 
primarily involves the increased formation of reactive 
oxygen species (ROS).(1,2) A decreased oxygen supply 
reduces the synthesis and resynthesis of ATP, creating 
an ionic gradient in the cell membrane due to decreased 
extracellular active calcium transport. The accumulation of 
cytoplasmic calcium leads to the activation of a protease 
that converts xanthine dehydrogenase to xanthine 
oxidase.(3) Concurrent with these events, there is an 
accumulation of AMP, which decomposes into substances 
such as adenosine, inosine, and hypoxanthine. During 
the reperfusion process, in the presence of oxygen, 
xanthine oxidase converts hypoxanthine into ROS, such 
as superoxide, peroxide, and hydroxyl radicals.(3,4) The 
release of ROS causes cell infl ammation and apoptosis 
of cells as a late phase response of IRI.(5)
Methylene blue (MB) prevents ROS production by acting 
as an alternative xanthine oxidase electron receptor, 
competing with molecular oxygen for electron transfer. 
The electrons are transferred to MB from the iron-sulfur 
center of xanthine oxidase, thus preventing the conversion 
of molecular oxygen into superoxide radicals.(4)
We previously demonstrated that MB was able to 
reduce the effects of IRI when we studied transplanted 
lungs of rats.(6) Some of the free radicals, proteases, and 
other mediators produced by ischemia and reperfusion 
after unilateral lung transplantation are washed out and 
released into the blood stream, and the mediators reach 
the contralateral lung. There have been few studies on 
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the effect of IRI after single-lung transplantation on 
the nonischemic lung.(7)
The objective of the present study was to evaluate 
the effects of MB as an inhibitor of IRI on nonischemic 
right lungs after left lung transplantation in rats.
METHODS
Forty female Sprague-Dawley rats (300-350 g) were 
used in the present study (20 donors/20 recipients). 
Recipient rats were divided into two groups (n = 10) 
according to treatment with saline solution (SAL) or 
MB, i.e., SAL group and MB group. The study was 
approved by our institutional research ethics committee 
(CAPPesq Protocol no. 3387/09/138) and performed 




The animals were anesthetized with 5% isofl urane 
(Isothane; Baxter, Jayuya, PR, USA), orotracheally 
intubated, and mechanically ventilated (model 683; 
Harvard Apparatus, Holliston, MA, USA) with a volume 
of 10 mL/kg and a respiratory rate of 80 breaths/min. 
General anesthesia was maintained with 2% isofl urane 
(Isovapor model 1224; Takaoka, São Paulo, Brazil). 
After median laparotomy, 500 U of heparin were 
injected into the inferior vena cava. After one minute, 
a median sternotomy was performed, and pulmonary 
artery was cannulated for anterograde perfusion 
with 20 mL of low-potassium dextran (LPD) solution 
(Perfadex®; Vitrolife, Kungsbacka, Sweden) at 4°C with 
constant pressure (20 cmH2O). Prior to perfusion, the 
inferior vena cava was sectioned to decrease venous 
return, and the left atrial appendage was amputated 
to drain the LPD solution. Animals were euthanized 
by exsanguination in accordance with the American 
Veterinary Medicine Association.(9)
After perfusion, the trachea of the animals was tied 
at the end of inspiratory fl ow, and the cardiopulmonary 
block was excised and placed into a Petri dish with 
cold LPD for back table procedure. The left hilum was 
dissected, and cuffs were applied to the artery, vein, 
and bronchus, as previously described.(10) Grafts were 
maintained infl ated during the ischemia period (3 h) 
and were stored in cold LPD until implantation.
Recipients
Recipient animals were anesthetized, intubated, and 
ventilated as described above. Immediately prior to graft 
implantation, animals were intraperitoneally injected 
with 2 mL of either 0.9% SAL or 1% MB solutions. 
Then, they were placed in right lateral recumbency 
and subjected to left thoracotomy at the fourth 
intercostal space. Subsequently, graft implantation 
was performed using a stereomicroscope (model 
SZ61; Olympus, Tokyo, Japan) at 8 magnifi cation. (10) 
In brief, the left hilum was dissected and clamped 
as proximally as possible. Then, graft implantation 
was performed by introducing the graft cuffs into a 
little hole made in the ventral wall of the artery, vein, 
and bronchus, respectively. After cuff fi xation using 
a 7.0-polypropylene silk suture, the bronchus clamp 
was slowly opened and air fl ow was reestablished. In 
sequence, the vein clamp was removed for retrograde 
circulation establishment, and, fi nally, the artery clamp 
was gently opened, aiming at a soft graft perfusion. 
The closure of the recipient incision was performed in 
separate layers using 2.0-monofi lament nylon sutures. 
After surgery completion, animals received analgesia 
(dipyrone, 400 mg/kg) by gavage and were placed 
under spontaneous ventilation in individual cages with 
free access to water and food.
Two hours after graft reperfusion, the animals were 
once more anesthetized, intubated and placed on 
mechanical ventilation, according to the previously 
mentioned parameters. The animals were subjected 
to exploratory laparotomy and euthanasia by incision 
of the anterior abdominal aorta, with subsequent 
removal of the cardiopulmonary block. Next, the 
blocks were stored in 4% formaldehyde solution over 
a period of 24 h, and, subsequently, kept in 70% ethyl 
alcohol solution until the preparation of the slides for 
histopathological and immunohistochemical analysis.
Histological analysis
Both lungs were fi xed by tracheal instillation of 4% 
formaldehyde solution (20 cmH2O) and stored for 
24 h in the same solution for histological analysis. 
Paraffi n-embedded lung samples were cut into 5-µm 
sections and stained with H&E. Histomorphometry by 
point-counting technique was used in order to quantify 
infl ammatory cells in lung parenchyma with a Weibel 
grid containing 100 points and 50 lines. Ten random 
and mismatched microscopic fi elds were examined 
(magnifi cation, ×400), totaling 1,000 points per slide 
and covering an area of 62,500 µm per fi eld.(11) The same 
methodology was used to evaluate the expression of 
intercellular adhesion molecule-1 (ICAM-1), caspase-3, 
and Bcl-2, which were evaluated through the analysis 
of slides prepared with a immunohistochemical method 
described by Almeida et al.(12)
Statistical analysis
Descriptive analysis was performed for quantitative 
data with normal distribution, and the results were 
expressed as mean ± SD. Normality of data distribution 
and homogeneity of variances were evaluated via the 
Shapiro-Wilk test and the Levene’s test, respectively. 
The t-test was used for dependent quantitative 
variables. A type I error of 0.05 (α) was considered 
for all inferential analyses.
RESULTS
Regarding infl ammatory cells in the lung parenchyma, 
mean neutrophil counts were higher in the SAL group 
in comparison with the MB group (5.2 ± 2.5% vs. 
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2.3 ± 0.8%; p = 0.04; Figure 1), as were ICAM-1 
expression (4.7 ± 0.8% vs. 2.7 ± 0.7%; p ≤ 0.001; 
Figure 2) and caspase-3 expression (4.4 ± 1.2% vs. 
3.0 ± 1.3%; p ≤ 0.001; Figure 3). However, Bcl-2 
expression in lung parenchyma was higher in the MB 
group in comparison with the SAL group (4.9 ± 1.9% 
vs. 2.5 ± 0.8%; p ≤ 0.001; Figure 4).
Data on the comparisons between the nonischemic 
lungs (right lungs) and the grafts (left lungs) of the 
animals in the SAL and in the MB groups are shown 
in Tables 1 and 2, respectively.
DISCUSSION
Lung IRI occurs in various cases, such as in 
cardiopulmonary bypass, lung transplantation, and 
postenucleation of pulmonary embolism. Recently, 
much attention has been paid to pulmonary dysfunction 
resulted from lung IRI.(13)
One-lung IRI can lead to similar, but less severe, 
injury in the contralateral lung. Because injury in the 
nonischemic lung develops only after reperfusion of the 
ischemic one, injury is probably humorally mediated.(14) 
In our study, we were able to confi rm this observation, 
because the native lungs showed a lower expression 
of infl ammatory and apoptotic markers both among 
the animals submitted to MB instillation and among 
the animals in the control group.
Contralateral lung injury induced by unilateral lung 
ischemia and reperfusion is a distinct and complicated 
phenomenon, which has yet to be fully understood.(15) 
Some authors have studied the injury of nonischemic 
lungs after ischemia and reperfusion of the left lung. 
Zhu et al.(16) used apocynin, an inhibitor of NADPH 
oxidase, in rats submitted to 60 min of ischemia by 
clamping the left pulmonary hilum followed by 30 
min of reperfusion. The authors observed that ROS 
produced by ischemia affected the nonischemic lung. 
Georgieva et al.(17) concluded that an injured organ 
affects a remote organ by liberating humoral mediators 
in an ischemia and reperfusion model similar to that 
of the study by Zhu et al.(16) To our knowledge, the 
present study is the fi rst one to assess these effects 
on nonischemic lungs after pulmonary ischemia and 
reperfusion induced by unilateral transplantation.
In a previous study,(6) our group evaluated the effects 
of MB on the lungs of rats submitted to unilateral lung 
Table 1. Comparison of the degree of infl ammation and apoptosis between nonischemic lungs and grafts in the control 
group.
Variable Graft (left lung) Nonischemic lung (right lung) p
Neutrophils, % 7.9 ± 2.0 5.2 ± 2.5 ≤ 0.001
ICAM-1, % 8.1 ± 2.1 4.7 ± 0.8 ≤ 0.001
Caspase-3, % 6.3 ± 2.9 4.4 ± 1.2 ≤ 0.001
Bcl-2, % 1.2 ± 0.9 2.5 ± 0.8 ≤ 0.001
ICAM-1: intercellular adhesion molecule-1.
Figure 1. Neutrophil infi ltration (%) in the saline group 
(SAL) and in the methylene blue (MB) group after 3-h 
cold ischemic time, transplantation, and 2-h reperfusion in 
nonischemic lungs after unilateral left lung transplantation. 
p ≤ 0,001.
Figure 2. Intercellular adhesion molecule-1 (ICAM-1) 
activity in the saline group (SAL) and in the methylene blue 
(MB) group after 3-h cold ischemic time, transplantation, 
and 2-h reperfusion in nonischemic lungs after unilateral 
left lung transplantation. p ≤ 0,001.
Figure 3. Caspase-3 activity (%) in the saline group (SAL) 
and in the methylene blue (MB) group after 3-h cold ischemic 
time, transplantation, and 2-h reperfusion in nonischemic 
lungs after unilateral left lung transplantation. p ≤ 0,001.
Figure 4. Bcl-2 activity (%) in the saline group (SAL) and 
in the methylene blue (MB) group after 3-h cold ischemic 
time, transplantation, and 2-h reperfusion in nonischemic 
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transplantation. As in the present study, MB was able 
to inhibit neutrophilic infi ltration according to the 
histopathological evaluation. The fi ndings in both studies 
show that MB, by means of inhibiting the production 
of ROS, is able to reduce infl ammation induced by IRI.
Apoptosis is regulated by a cascade of proteins 
called caspases, which are activated in ischemia and 
reperfusion events. Lung ischemia and reperfusion 
has a direct effect on lung cells, and the increase 
in caspase-3 activity refl ected a larger number of 
apoptotic cells.(18)
The signaling pathways that lead to apoptosis are 
maintained by positive and negative regulators. The 
proteins that promote survival are the antiapoptotic 
proteins Bcl-2 and Bcl-xL.(19) The release of ROS 
causes cell apoptosis as a late phase response of 
IRI. Oxidative stress triggers caspase-3 activation, 
leading to cell apoptosis. In addition, the balance of 
anti- and pro-apoptotic proteins responds dramatically 
to ROS.(5) Decreased Bcl-2 and increased caspase-3 
expressions in the present study are similar to those 
found by Abogresha et al.,(5) who used vitamin C as 
an antioxidant agent, protecting against the effects 
of pancreatic injury after renal ischemia. The fi ndings 
of the present study show the induction of apoptosis 
as a result of IRI injury after lung transplantation and 
the ability of MB to inhibit its occurrence.
Endothelial cell adhesion molecules seem to play an 
important role in IRI by causing adhesion of leukocytes 
to endothelial cells. ICAM-1 is one of the adhesion 
molecules that have been shown to be upregulated 
in response to cytokines. This upregulation leads to 
leukocyte-endothelial cell adhesion and to neutrophil 
infi ltration in the affected tissue. Meyer et al.(20) 
performed 45 min of hepatic ischemia followed by 5 
h of reperfusion and showed a signifi cant upregulation 
in ICAM-1 in distant organs, such as the heart, kidney, 
intestine, and pancreas. In the present study, we were 
able to identify a higher expression of ICAM-1 in the 
lungs of rats in the SAL group in comparison with those 
in the MB group, as well as a higher neutrophil count, 
both of which represent a less intense infl ammatory 
process in the animals treated with MB.
As a limitation of our study, we can highlight that 
we used the same dose of MB in all cases. MB has 
a dose-dependent effect, and a study with different 
doses could have produced different results than 
those found in the present study. In addition, the 
monitoring of hemodynamic parameters, markers of 
tissue perfusion, and ventilation parameters could be 
useful for a better understanding of the action of MB.
To our knowledge, the present study demonstrates 
for the fi rst time that MB is an effective drug for the 
protection of nonischemic lungs against infl ammation and 
apoptosis following unilateral lung transplantation in rats.
Table 2. Comparison of the degree of infl ammation and apoptosis between nonischemic lungs and grafts in the 
methylene blue group.
Variable Graft (left lung) Nonischemic lung (right lung) p
Neutrophils, % 4.4 ± 1.4 2.3 ± 0.8 ≤ 0.001
ICAM-1, % 5.1 ± 1.1 2.7 ± 0.7 ≤ 0.001
Caspase-3, % 5.7 ± 1.8 3.0 ± 1.3 ≤ 0.001
Bcl-2, % 2.2 ± 1.1 4.9 ± 1.9 ≤ 0.001
ICAM-1: intercellular adhesion molecule-1.
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